Caidya

Caidya is a full-service, global clinical research organization (CRO) formed from the April 2021 merger of dMed and Clinipace, rebranded to Caidya in October 2022. It runs clinical development programs end to end — pre-IND and regulatory strategy, early phase, Phase II/III delivery, study start-up, trial feasibility, clinical operations, risk-based quality management, medical monitoring, clinical data management, biometrics, medical writing, pharmacovigilance, quality assurance and post-marketing surveillance — across oncology and hematology, cardiovascular-metabolic, rare disease, pediatrics, gastroenterology, nephrology, dermatology, ophthalmology, cell and gene therapy, neurology, immunology and infectious disease. The company took a $165M strategic growth investment from Rubicon Founders and announced a strategic combination with Simbec-Orion. Caidya is a clinical services provider rather than a software vendor: it integrates with sponsor-preferred EDC, eCOA, IRT, CTMS, eTMF and safety platforms rather than publishing a developer program or a public API of its own.

Caidya is profiled on the APIs.io network. Tagged areas include Company, Clinical Research, Contract Research Organization, Healthcare, and Life Sciences.

Caidya’s developer surface includes engineering blog, product news, support, and 8 more developer resources.

🌐 Visit website 📡 Source on GitHub
16.7/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyClinical ResearchContract Research OrganizationHealthcareLife SciencesPharmaceuticalsClinical TrialsClinical Data ManagementPharmacovigilanceRegulatory AffairsBiometricsOncology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 16.7/100 · emerging
Contract Quality 0.0 / 21
Developer Ergonomics 1.1 / 17
Commercial Clarity 4.9 / 17
Operational Transparency 0.0 / 11
Governance 1.3 / 10
Discoverability 4.9 / 9
Regulatory Posture 4.5 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/caidya: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Caidya Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Conformance
Conformance

Access & Security 2

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity
 Compliance
Compliance

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 3

The organization behind the API

Website
Website
 Blog
Blog
 News
News

Other 1

Properties that don't map to a standard resource type

SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: caidya
name: Caidya
description: 'Caidya is a full-service, global clinical research organization (CRO) formed from the April 2021 merger of dMed
  and Clinipace, rebranded to Caidya in October 2022. It runs clinical development programs end to end — pre-IND and regulatory
  strategy, early phase, Phase II/III delivery, study start-up, trial feasibility, clinical operations, risk-based quality
  management, medical monitoring, clinical data management, biometrics, medical writing, pharmacovigilance, quality assurance
  and post-marketing surveillance — across oncology and hematology, cardiovascular-metabolic, rare disease, pediatrics, gastroenterology,
  nephrology, dermatology, ophthalmology, cell and gene therapy, neurology, immunology and infectious disease. The company
  took a $165M strategic growth investment from Rubicon Founders and announced a strategic combination with Simbec-Orion.
  Caidya is a clinical services provider rather than a software vendor: it integrates with sponsor-preferred EDC, eCOA, IRT,
  CTMS, eTMF and safety platforms rather than publishing a developer program or a public API of its own.'
image: https://www.caidya.com/wp-content/uploads/2026/06/og-image.png
url: https://raw.githubusercontent.com/api-evangelist/caidya/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Clinical Research
- Contract Research Organization
- Healthcare
- Life Sciences
- Pharmaceuticals
- Clinical Trials
- Clinical Data Management
- Pharmacovigilance
- Regulatory Affairs
- Biometrics
- Oncology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/caidya-domain-security.yml
- type: Website
  url: https://www.caidya.com/
- type: Blog
  url: https://www.caidya.com/blog/
- type: News
  url: https://www.caidya.com/news/
- type: Support
  url: https://www.caidya.com/contact/
- type: PrivacyPolicy
  url: https://www.caidya.com/privacy-notices/
- type: TermsOfService
  url: https://www.caidya.com/disclaimer/
- type: LLMsTxt
  url: llms/caidya-llms.txt
- type: Conformance
  url: conformance/caidya-conformance.yml
- type: Compliance
  url: https://www.caidya.com/privacy-notices/
- type: SecondaryMarket
  url: https://www.hiive.com/securities/caidya-stock
x-enrichment:
  date: '2026-08-08'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Caidya is a clinical research organization that explicitly positions itself as an integrator of the sponsor's preferred
    EDC, eCOA, IRT, CTMS, eTMF and safety platforms rather than a publisher of its own — there is no developer portal, no
    api./developer. subdomain (both NXDOMAIN), and the only machine-readable file on the whole estate is a Yoast-generated
    marketing llms.txt.
  evidence:
  - url: https://www.caidya.com/llms.txt
    status: 200
  - url: https://www.caidya.com/openapi.json
    status: 404
  - url: https://www.caidya.com/.well-known/agent-card.json
    status: 404
  - url: https://www.caidya.com/.well-known/security.txt
    status: 404
  - url: https://www.caidya.com/about/clinical-technology-ecosystem/
    status: 200
  checked: '2026-08-08'